Clinically achievable doses of mifepristone also inhibited the growth of three endometrial cancer cell lines (Hec-1A, LEK, and RL95-2), while inducing a decline in the abundance of GR (Schneider et al. 1998). Here, NR3C1 is linked to endometrial cancer.